The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR platform, marking the first patent issued for this point-of-care technology.

CO-DIAGNOSTIC ($CODX) posted quarterly earnings results on Thursday, March 27th. The company reported earnings of -$0.36 per share, missing estimates of -$0.35 by $0. ...

CO-DIAGNOSTIC ($CODX) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of ...

Co-Diagnostics ( (CODX)) has issued an announcement. On March 9, 2026, Co-Diagnostics, Inc. received formal notice from Nasdaq that it had regained compliance with the $1.00 minimum bid price ...

Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

In a recent SEC filing, Co-Diagnostics , Inc. (NASDAQ:CODX) disclosed the results of its annual shareholder meeting held on... In a notable surge, Co-Diagnostics Inc. (NASDAQ:CODX) stock achieved a 52 ...

Co-Diagnostics (NASDAQ:CODX) just reported results for the second quarter of 2024. Co-Diagnostics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -34 cents.